Frontlight ResearchEarly access
Acute myeloid leukaemia trials in United States
334 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies
- Where
- Charlotte, Houston, Winston-Salem
- People
- 49
- Run by
- ARCE Therapeutics, Inc.
See details and how to joinNCT06906380 - Phase 3Taking peoplePivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Where
- Ann Arbor, Augusta, Baltimore, Birmingham, Buffalo, Chapel Hill, Charlottesville, Columbus, Duarte, Houston, Irvine, Lexington, Los Angeles, Nashville, Orange, Stanford, The Bronx
- Age
- 18 years to 71 years
- People
- 150 worldwide
- Run by
- Quetzal Therapeutics
See details and how to joinNCT07504458 · EU 2025-524810-28-00 - No phaseTaking peopleCancer Experience Registry (CER) for Cancer Patients and Caregivers
- Where
- Washington D.C.
- Age
- 18 years and over
- People
- 15,000
- Run by
- Cancer Support Community, Research and Training Institute, Philadelphia
See details and how to joinNCT02333604 - No phaseTaking peoplePharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
- Where
- Atlanta, Aurora, Cincinnati, Houston, Milwaukee, Philadelphia
- Age
- 0 years to 38 years
- People
- 30
- Run by
- Children's Hospital Medical Center, Cincinnati
See details and how to joinNCT06131801 - Phase 1Taking peopleStudy of REM-422 in Patients With AML or Higher Risk MDS
- Where
- Boston, Duarte, Houston, New York, Tampa
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- Remix Therapeutics
See details and how to joinNCT06297941 - Phase 1Taking peopleProphylactic DLI-X for Leukemia Relapse After HCT
- Where
- Tucson
- Age
- Up to 65 years
- People
- 180
- Run by
- University of Arizona
See details and how to joinNCT07254793 - No phaseNot yet taking people in United Statesmy.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults
- Where
- Boston
- Age
- 15 years to 24 years
- People
- 143
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT07516353 - No phaseTaking peopleA Home-Based Exercise Intervention (CAREFit-BMT) in Improving Heart Function Among Patients With High Risk Acute Myeloid Leukemia Undergoing Stem Cell Transplant
- Where
- Seattle
- Age
- 18 years and over
- People
- 30
- Run by
- University of Washington
See details and how to joinNCT07616921 - Phase 1Taking peopleFH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Disease Positive Acute Myeloid Leukemia
- Where
- Seattle
- Age
- 18 years and over
- People
- 9
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT07645469 - No phaseTaking peopleTissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
- Where
- Chapel Hill
- Age
- 18 years to 120 years
- People
- 15,000
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT01137643 - Phase 1/2Taking peopleCLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
- Where
- Atlanta, Aurora, Birmingham, Boston, Buffalo, Cincinnati, Duarte, Durham, Houston, Jacksonville, Los Angeles, Miami, New York, Phoenix, Rochester, Tampa
- Age
- 18 years and over
- People
- 275
- Run by
- Cullinan Therapeutics Inc.
See details and how to joinNCT05143996 - Phase 2Taking peopleComparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
- Where
- Albany, Albuquerque, Allentown, Anaconda, Appleton, Ashland, Basking Ridge, Baton Rouge, Bellevue, Berkeley, Bethesda, Billings, Birmingham, Boiling Springs, Boise, Boston, Bozeman, Brighton, Buffalo, Burlington, Caldwell, Canton, Centralia, Charlotte, Charlottesville, Chelsea, Chicago, City of Saint Peters, Cleveland, Clinton Township, Coeur d'Alene, Collierville, Columbus, Commack, Coon Rapids, Creve Coeur, Crown Point, Danville, Decatur, Deer River, Detroit, Duluth, Durham, Easley, Edina, Edmonds, Effingham, Evanston, Fairfax, Fairway, Falls Church, Flint, Fruitland, Glenview, Great Falls, Green Bay, Greenville, Greer, Grenada, Hershey, Hibbing, Highland Park, Houston, Iowa City, Issaquah, Jackson, Kalispell, Kansas City, Knoxville, La Crosse, Las Vegas, Lebanon, Lewistown, Lexington, Little Rock, Livingston, Livonia, Long Branch, Los Angeles, Louisville, Maywood, Memphis, Meridian, Miami, Middletown, Milwaukee, Minneapolis, Missoula, Montvale, Nampa, New Albany, New Brunswick, New Haven, New Lenox, New York, Novi, Oakland, O'Fallon, Oklahoma City, Omaha, Ontario, Orland Park, Overland Park, Oxford, Paramus, Peabody, Pembroke Pines, Pittsburgh, Pontiac, Portland, Post Falls, Providence, Ridgewood, Rochester, Roseville, Saint Louis Park, Saint Paul, Salt Lake City, Sandpoint, Sandstone, San Francisco, Santa Clara, Scarborough, Seattle, Seneca, Southhaven, South Portland, Springfield, Stevens Point, St Louis, Stony Brook, The Bronx, Toms River, Tucson, Uniondale, Virginia, West Bloomfield, Weston, West Reading, Westwood, Wilkes-Barre, Winston-Salem, Ypsilanti
- Age
- 18 years to 59 years
- People
- 153 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05554393 - Phase 1Not yet taking people in United StatesA Phase 1b Study of CLN-049 in Combination With Azacitidine and Venetoclax in AML Patients
- Where
- Atlanta, Duarte, Houston, Miami, New York
- Age
- 18 years and over
- People
- 90
- Run by
- Cullinan Therapeutics Inc.
See details and how to joinNCT07722767 - Phase 1Taking peopleAlpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- Where
- Madison
- Age
- 7 months to 21 years
- People
- 22
- Run by
- University of Wisconsin, Madison
See details and how to joinNCT02508038 - Phase 2Taking peopleComparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
- Where
- Albuquerque, Anaconda, Ashland, Augusta, Basking Ridge, Baton Rouge, Berkeley, Billings, Boiling Springs, Boise, Boston, Bozeman, Brighton, Brunswick, Buffalo, Canton, Charlotte, Chelsea, Chicago, Clinton Township, Coeur d'Alene, Commack, Coon Rapids, Crown Point, Danville, Deer River, DeKalb, Detroit, Duluth, Durham, Easley, Edina, Edmonds, Escanaba, Evanston, Fairway, Flint, Fruitland, Geneva, Glenview, Grayslake, Great Falls, Green Bay, Greenville, Greer, Harrison, Hibbing, Highland Park, Hines, Hollywood, Issaquah, Jackson, Kalispell, Kansas City, Knoxville, La Crosse, Lake Forest, Lebanon, Little Rock, Livingston, Livonia, Long Branch, Louisville, Madison, Maywood, Meridian, Miami, Middletown, Milwaukee, Minneapolis, Missoula, Montvale, Nampa, New Brunswick, New Lenox, New York, Novi, Oconto Falls, Oklahoma City, Orland Park, Pembroke Pines, Philadelphia, Pittsburgh, Pontiac, Portland, Post Falls, Providence, Richmond, Rochester, Saint Louis Park, Saint Paul, Salt Lake City, Sandpoint, Sandstone, San Francisco, San Mateo, Scarborough, Seattle, Seneca, Sheboygan, South Portland, Stevens Point, Stony Brook, Sturgeon Bay, Syracuse, Toms River, Tucson, Uniondale, Virginia, Warrenville, West Bloomfield, Weston, Westwood, Wilkes-Barre, Winston-Salem, Ypsilanti
- Age
- 18 years and over
- People
- 93 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06672146 - Phase 1Taking peopleGenetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
- Where
- Buffalo
- Age
- 18 years and over
- People
- 26
- Run by
- Roswell Park Cancer Institute
See details and how to joinNCT06871410 - Phase 2Taking peopleCord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
- Where
- Seattle
- Age
- 6 months to 65 years
- People
- 54
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT06013423 - No phaseTaking peopleImmune Profile of Acute Myeloid Leukemia Patients Receiving Azacitidine Plus Venetoclax Induction Chemotherapy
- Where
- Jacksonville, Rochester, Scottsdale
- Age
- 18 years and over
- People
- 100
- Run by
- Mayo Clinic
See details and how to joinNCT06279572 - Phase 2Taking peopleCMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
- Where
- Atlanta, Boston, Duarte
- Age
- 18 years to 75 years
- People
- 216
- Run by
- City of Hope Medical Center
See details and how to joinNCT06059391 - Phase 1/2Taking peopleA Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)
- Where
- Buffalo, Chicago, Columbus, Duarte, Grand Rapids, Houston, Tampa
- Age
- 18 years and over
- People
- 154
- Run by
- Debiopharm International SA
See details and how to joinNCT06969430 - Phase 1/2Taking peoplePhase I/II Clinical Trial of Proteasome Inhibitor in Combination With CPX-351 for the Treatment of Newly-Diagnosed TP53-mutated Acute Myeloid Leukemia (AML)
- Where
- Minneapolis
- Age
- 18 years and over
- People
- 32
- Run by
- Masonic Cancer Center, University of Minnesota
See details and how to joinNCT07008638 - Phase 1Taking peopleA Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
- Where
- Ann Arbor, Atlanta, Aurora, Birmingham, Chicago, Cincinnati, Houston, Indianapolis, Memphis, Minneapolis, New York, Philadelphia, Pittsburgh, San Francisco, Seattle
- Age
- Up to 21 years
- People
- 47
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07012044 - Phase 1Taking peopleA Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
- Where
- Atlanta, Boston, Duarte
- Age
- 18 years to 75 years
- People
- 46
- Run by
- City of Hope Medical Center
See details and how to joinNCT07020533 - Phase 1/2Taking peopleStudy of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
- Where
- Chapel Hill, Decatur, Durham, Houston, New York, Portland
- Age
- 16 years and over
- People
- 85 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07155226 · EU 2025-521299-76-00 - Phase 1Taking peopleStudy of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
- Where
- Atlanta, Aurora, Cincinnati, Dallas, Fort Worth, Kansas City, Memphis, New York, Philadelphia, San Diego
- Age
- 1 year to 30 years
- People
- 24
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT06177067